Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice (Q70264573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Effects of beta-lactam antibiotics imipenem/cilastatin and cefodizime on cellular and humoral immune responses in BALB/c-mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

Grochla I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Ko HL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Beuth J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Roszkowski K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Roszkowski W

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Pulverer G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 November 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

Zentralblatt fur Bakteriologie : international journal of medical microbiology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

250-258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Tuberculin-induced migration inhibition of human peripheral leucocytes in agarose medium

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Influence of sublethal concentrations of antibiotics on the expression of the mannose-specific ligand of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Imipenem versus moxalactam in the treatment of serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Effect of antibiotics on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Clinical evaluation of moxalactam

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

In vitro activity of N-formimidoyl thienamycin (MK0787).

1 reference

https://api.crossref.org/works/10.1016%2FS0934-8840%2811%2980108-8

7 January 2021

10.1016/S0934-8840(11)80108-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2085374%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference